2012
DOI: 10.1016/j.jbiosc.2011.09.007
|View full text |Cite
|
Sign up to set email alerts
|

Display of the antigenic region of Nipah virus nucleocapsid protein on hepatitis B virus capsid

Abstract: The C-terminal domain of Nipah virus (NiV) nucleocapsid protein (NP₄₀₁₋₅₃₂) was inserted at the N-terminus and the immunodominant loop of hepatitis B core antigen (HBc). The stability of NP₄₀₁₋₅₃₂ increased tremendously when displayed on the HBc particles. These particles reacted specifically with the swine anti-NiV and the human anti-HBc antisera.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
1
1

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 11 publications
0
9
0
Order By: Relevance
“…VLPs formed by the capsid proteins of viruses such as HBV (25,27,32) and human papillomavirus (33) and bacteriophages (8,34) have been widely used for displaying foreign epitopes for vaccine development. The carriers enhance the antigenicity of the fused epitopes (35)(36)(37), which are often found to be inefficient in eliciting immune responses.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…VLPs formed by the capsid proteins of viruses such as HBV (25,27,32) and human papillomavirus (33) and bacteriophages (8,34) have been widely used for displaying foreign epitopes for vaccine development. The carriers enhance the antigenicity of the fused epitopes (35)(36)(37), which are often found to be inefficient in eliciting immune responses.…”
Section: Discussionmentioning
confidence: 99%
“…The recombinant MrNV capsid protein expressed in Escherichia coli self-assembled into VLPs in the absence of other viral proteins (18,19). VLPs have been widely used for various purposes, including drug delivery (20,21), gene therapy (22), vaccine development (23)(24)(25)(26)(27), and display of epitopes (28). Therefore, it is hypothesized that the VLPs of MrNV capsid protein can be used to display foreign epitopes.…”
mentioning
confidence: 99%
“…VLPs have been widely used for displaying foreign epitopes, for instance the VLPs of human papilloma virus ( Matic et al, 2011 ), HBV ( Ibañez et al, 2013 ; Murray & Shiau, 1999 ; Yap et al, 2012 ), as well as bacteriophages ( Hashemi et al, 2012 ; Kok et al, 2002 ; Tan et al, 2005 ; Wan et al, 2001 ). VLPs are known to enhance the immunogenicity of small epitopes displayed on the particles ( Murata et al, 2003 ; Quan et al, 2008 ).…”
Section: Survey Methodologymentioning
confidence: 99%
“…The self‐assembly capability of HBcAg can be manipulated to display foreign epitopes on the VLP. These epitopes derived from foot‐and‐mouth disease virus, plasmodium spp ., influenza virus, and anthrax protective antigen . Due to its potential applications in the development of multicomponent vaccines and diagnostic reagents, hence it is of importance to establish an effective method to purify and to separate the HBcAg large and small particles.…”
Section: Introductionmentioning
confidence: 99%